Antimicrobial activity of the semisynthetic compound, hexahydrocolupulone
Author(s) -
Thomas Stephan,
E O Ngo,
Patricia Ferrieri,
John M. Besser,
Louise M. Nutter
Publication year - 1998
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/42.4.519
Subject(s) - microbiology and biotechnology , enterococcus faecium , staphylococcus aureus , bacillus subtilis , antimicrobial , mycobacterium tuberculosis , escherichia coli , vancomycin , biology , enterococcus , chemistry , antibiotics , bacteria , tuberculosis , medicine , biochemistry , genetics , pathology , gene
In this study we demonstrate that hexahydrocolupulone (HHC) more effectively inhibits the growth in vitro of Gram-positive organisms than Mycobacterium tuberculosis or Escherichia coli. Vancomycin-resistant Enterococcus faecium, methicillin-resistant Staphylococcus aureus, and coagulase-negative staphylococci were inhibited by HHC at concentrations < or = 4.06 mg/L. Growth inhibition profiles varied according to the microorganism evaluated (static for S. aureus and bactericidal for Bacillus subtilis).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom